| 1 |
Role of metronomic therapy for advanced oral cancers and predictors of response: A multi-institutional feasibility study |
|
|
| Mahesh Sultania, Mohammed Imaduddin, Suryanarayana Deo, Madhabananda Kar, Dillip Muduly, Sunil Kumar, Atul Sharma, Ashutosh Mishra, Saroj Majumdar, Amit Adhya, Dilip Parida |
|
| Head & Neck. 2021; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Advances in pharmacotherapy for head and neck cancer |
|
|
| Shikhar kumar, Vanita Noronha, Vijay Patil, Amit Joshi, Nandini Menon, Kumar Prabhash |
|
| Expert Opinion on Pharmacotherapy. 2021; 22(15): 2007 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Precision Medicine Gains Momentum: Novel 3D Models and Stem Cell-Based Approaches in Head and Neck Cancer |
|
|
| Annette Affolter, Anne Lammert, Johann Kern, Claudia Scherl, Nicole Rotter |
|
| Frontiers in Cell and Developmental Biology. 2021; 9 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Ex Vivo Expanded Circulating Tumor Cells for Clinical Anti-Cancer Drug Prediction in Patients with Head and Neck Cancer |
|
|
| Kuan-Chou Lin, Lai-Lei Ting, Chia-Lun Chang, Long-Sheng Lu, Hsin-Lun Lee, Fang-Chi Hsu, Jeng-Fong Chiou, Peng-Yuan Wang, Thierry Burnouf, Dennis Chun-Yu Ho, Kai-Chiang Yang, Chang-Yu Chen, Chu-Huang Chen, Ching-Zong Wu, Yin-Ju Chen |
|
| Cancers. 2021; 13(23): 6076 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Ex Vivo Culture Models to Indicate Therapy Response in Head and Neck Squamous Cell Carcinoma |
|
|
| Imke Demers, Johan Donkers, Bernd Kremer, Ernst Jan Speel |
|
| Cells. 2020; 9(11): 2527 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Biomarkers: paving stones on the road towards the personalized precision medicine for oral squamous cell carcinoma |
|
|
| Liang Zhong,Yutong Liu,Kai Wang,Zhijing He,Zhaojian Gong,Zhili Zhao,Yaocheng Yang,Xiaofei Gao,Fangjie Li,Hanjiang Wu,Sheng Zhang,Lin Chen |
|
| BMC Cancer. 2018; 18(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
Sponge-supported cultures of primary head and neck tumors for an optimized preclinical model |
|
|
| Amy J.C. Dohmen, Joyce Sanders, Sander Canisius, Ekaterina S. Jordanova, Else A. Aalbersberg, Michiel W.M. van den Brekel, Jacques Neefjes, Charlotte L. Zuur |
|
| Oncotarget. 2018; 9(38): 25034 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
Feasibility of Primary Tumor Culture Models and Preclinical Prediction Assays for Head and Neck Cancer: A Narrative Review |
|
|
| Amy Dohmen,Justin Swartz,Michiel Van Den Brekel,Stefan Willems,René Spijker,Jacques Neefjes,Charlotte Zuur |
|
| Cancers. 2015; 7(3): 1716 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 9 |
A prospective randomized phase II study comparing metronomic chemotherapy with chemotherapy (single agent cisplatin), in patients with metastatic, relapsed or inoperable squamous cell carcinoma of head and neck |
|
|
| Vijay Maruti Patil,Vanita Noronha,Amit Joshi,Vamshi Krishna Muddu,Sachin Dhumal,Bharatsingh Bhosale,Supreeta Arya,Shashikant Juvekar,Shripad Banavali,Anil D’Cruz,Atanu Bhattacharjee,Kumar Prabhash |
|
| Oral Oncology. 2015; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 10 |
TS mRNA levels can predict pemetrexed and raltitrexed sensitivity in colorectal cancer |
|
|
| Qun Zhang,Jie Shen,Hao Wang,Jing Hu,Lixia Yu,Li Xie,Jia Wei,Baorui Liu,Wenxian Guan,Xiaoping Qian |
|
| Cancer Chemotherapy and Pharmacology. 2013; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 11 |
Oral Metronomic Chemotherapy in Recurrent, Metastatic and Locally Advanced Head and Neck Cancers |
|
|
| V. Patil,V. Noronha,V. Krishna,A. Joshi,K. Prabhash |
|
| Clinical Oncology. 2013; 25(6): 388 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 12 |
Oral Metronomic Chemotherapy in Recurrent, Metastatic and Locally Advanced Head and Neck Cancers |
|
|
| Patil, V. and Noronha, V. and Krishna, V. and Joshi, A. and Prabhash, K. |
|
| Clinical Oncology. 2013; 25(6): 388 |
|
| [Pubmed] [Google Scholar] |
|
| 13 |
Personalized primary tumor xenograft model established for the pre-clinical trial to guide postoperative chemotherapy |
|
|
| Han, C. and Shen, J. and Wang, H. and Yu, L. and Qian, X. and Liu, B. and Guan, W. |
|
| Medical Hypotheses. 2012; 79(6): 705-708 |
|
| [Pubmed] [Google Scholar] |
|
| 14 |
Personalized primary tumor xenograft model established for the pre-clinical trial to guide postoperative chemotherapy |
|
|
| Chenglong Han,Jie Shen,Hao Wang,Lixia Yu,Xiaoping Qian,Baorui Liu,Wenxian Guan |
|
| Medical Hypotheses. 2012; 79(6): 705 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 15 |
Chemotherapy for Malignant Gliomas Based on Histoculture Drug Response Assay : A Pilot Study |
|
|
| Ho-Shin Gwak,Hyeon Jin Park,Heon Yoo,Sang Min Youn,Chang Hun Rhee,Seung Hoon Lee |
|
| Journal of Korean Neurosurgical Society. 2011; 50(5): 426 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 16 |
Chemotherapy for malignant gliomas based on histoculture drug response assay: A pilot study |
|
|
| Gwak, H.-S. and Park, H.J. and Yoo, H. and Youn, S.M. and Rhee, C.H. and Lee, S.H. |
|
| Journal of Korean Neurosurgical Society. 2011; 50(5): 426-433 |
|
| [Pubmed] [Google Scholar] |
|
| 17 |
Prediction of chemotherapeutic effect on postoperative recurrence by in vitro anticancer drug sensitivity testing in non-small cell lung cancer patients |
|
|
| Masahiko Higashiyama,Kazuyuki Oda,Jiro Okami,Jun Maeda,Ken Kodama,Fumio Imamura,Kazuhiko Minamikawa,Toshikazu Takano,Hisayuki Kobayashi |
|
| Lung Cancer. 2010; 68(3): 472 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 18 |
Prediction of chemotherapeutic effect on postoperative recurrence by in vitro anticancer drug sensitivity testing in non-small cell lung cancer patients |
|
|
| Higashiyama, M. and Oda, K. and Okami, J. and Maeda, J. and Kodama, K. and Imamura, F. and Minamikawa, K. and Takano, T. and Kobayashi, H. |
|
| Lung Cancer. 2010; 68(3): 472-477 |
|
| [Pubmed] [Google Scholar] |
|
| 19 |
Analysis of in vitro and in vivo sensitivity of oral cancer cells to methotrexate |
|
|
| Pai, R.B., Lalitha, R.M., Pai, S.B., Kumaraswamy, S.V., Lalitha, N., Bhargava, M.K. |
|
| Experimental Oncology. 2009; 31(2): 118-120 |
|
| [Pubmed] [Google Scholar] |
|
| 20 |
Progress of individualized chemotherapy guided by chemosensitivity test |
|
|
| Mi, Y.-J., Zhang, C.-Z., Fu, L.-W. |
|
| Yaoxue Xuebao. 2009; 44(11): 1187-1192 |
|
| [Pubmed] [Google Scholar] |
|
